Insider Trading activities of Vertex Pharmaceuticals Inc / Ma (VRTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma (VRTX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma since year 2005. Table 2 shows the detailed insider transactions of Vertex Pharmaceuticals Inc / Ma since 2005. The reporting company's ticker symbol is VRTX. The reporting company's CIK number is 875320.
The total value of stock buying since 2005 is $3,407,145.
The total value of stock sales since 2005 is $1,116,241,638.
The total value of stock option exercises since 2005 is $391,047,217.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Vertex Pharmaceuticals Inc / Ma (VRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 0 $0 5,000 $1,125,000 5,000 $545,700
2019-11 0 $0 156,115 $32,870,628 155,829 $19,537,759
2019-10 0 $0 158,775 $29,940,498 156,214 $17,819,636
2019-08 0 $0 30,664 $5,631,694 30,664 $2,917,349
2019-07 0 $0 6,375 $1,138,213 6,375 $712,278
2019-06 0 $0 58,875 $10,352,455 58,155 $4,611,945
2019-05 0 $0 153,297 $26,809,708 152,527 $11,857,222
2019-04 0 $0 11,999 $2,186,843 6,375 $678,108
2019-02 0 $0 119,483 $22,343,068 20,610 $1,880,383
2019-01 0 $0 18,523 $3,450,365 18,523 $2,306,123
2018-12 0 $0 809 $150,894 10,809 $412,394
2018-11 0 $0 22,991 $4,009,752 22,760 $2,255,305
2018-10 0 $0 16,574 $3,139,552 13,193 $1,572,675
2018-08 0 $0 24,859 $4,368,326 24,859 $2,443,361
2018-07 0 $0 53,720 $9,647,012 53,720 $6,334,770
2018-06 0 $0 180,014 $28,978,759 145,428 $13,522,627
2018-05 0 $0 3,152 $476,383 2,330 $201,591
2018-04 0 $0 6,422 $1,044,561 2,984 $283,407
2018-03 0 $0 23,750 $4,106,250 23,750 $2,147,362
2018-02 0 $0 59,196 $9,797,859 40,382 $3,732,244
2018-01 0 $0 286,406 $45,640,676 229,379 $15,782,594
2017-12 0 $0 126,289 $17,923,202 1,289 $99,652
2017-11 0 $0 26,088 $3,825,339 25,448 $2,272,107
2017-10 0 $0 265,695 $38,842,346 11,530 $1,022,637
2017-08 0 $0 26,999 $4,177,570 26,999 $2,455,096
2017-07 0 $0 631,042 $101,355,071 557,943 $42,701,259
2017-06 0 $0 373,878 $47,641,999 374,320 $19,518,498
2017-05 0 $0 9,841 $1,185,726 8,979 $817,537
2017-04 0 $0 203,332 $24,234,447 186,166 $7,153,326
2017-03 0 $0 95,938 $10,351,946 95,938 $4,518,461
2017-02 0 $0 56,147 $4,930,221 0 $0
2017-01 0 $0 14,500 $1,164,108 14,500 $526,349
2016-12 0 $0 26,000 $1,968,276 26,000 $943,796
2016-11 0 $0 38,887 $3,375,990 37,562 $1,383,622
2016-10 0 $0 27,208 $2,253,646 26,000 $943,796
2016-09 0 $0 26,000 $2,391,642 26,000 $943,796
2016-08 0 $0 77,000 $7,701,014 32,500 $1,179,745
2016-07 0 $0 24,640 $2,239,858 24,640 $889,546
2016-06 0 $0 25,650 $2,318,543 25,650 $906,725
2016-05 0 $0 24,041 $2,041,388 20,520 $725,380
2016-04 0 $0 20,520 $1,756,166 20,520 $725,380
2016-03 0 $0 25,650 $2,154,181 25,650 $906,725
2016-02 0 $0 66,083 $5,930,071 20,520 $725,380
2016-01 0 $0 43,525 $4,475,385 43,733 $1,587,476
2015-12 0 $0 85,156 $10,700,825 85,364 $3,873,690
2015-11 0 $0 127,219 $16,253,502 110,663 $5,790,352
2015-10 0 $0 121,343 $14,092,377 62,933 $2,243,764
2015-09 0 $0 69,088 $8,516,356 62,396 $2,416,665
2015-08 0 $0 83,928 $11,572,308 83,928 $3,754,570
2015-07 0 $0 61,801 $7,913,701 61,801 $2,034,302
2015-06 0 $0 59,300 $7,502,265 59,300 $1,930,020
2015-05 0 $0 51,693 $6,485,705 52,401 $1,545,757
2015-04 0 $0 206,005 $26,401,840 195,400 $9,427,267
2015-03 0 $0 125,875 $16,033,942 112,500 $3,805,760
2015-02 0 $0 93,863 $10,617,688 40,701 $1,246,571
2015-01 0 $0 83,729 $10,314,384 83,729 $2,633,060
2014-12 0 $0 112,829 $13,270,705 53,437 $1,156,529
2014-11 0 $0 177,560 $20,359,064 124,600 $4,180,421
2014-10 0 $0 170,462 $18,917,894 82,524 $3,338,204
2014-09 0 $0 614,912 $67,819,473 611,350 $24,213,519
2014-08 0 $0 20,800 $1,871,453 21,000 $241,194
2014-07 0 $0 51,361 $4,842,828 48,321 $1,968,186
2014-06 0 $0 79,984 $7,565,156 79,984 $2,737,301
2014-05 0 $0 8,869 $596,829 7,500 $241,199
2014-04 0 $0 10,000 $639,535 10,000 $314,550
2014-03 0 $0 16,200 $1,240,745 7,500 $216,300
2014-02 0 $0 52,682 $4,261,519 8,438 $258,613
2014-01 0 $0 62,888 $5,067,886 52,500 $1,565,400
2013-12 0 $0 46,529 $3,110,960 9,837 $279,352
2013-11 0 $0 25,579 $1,643,464 17,036 $387,868
2013-10 0 $0 38,498 $2,902,229 17,031 $324,029
2013-09 0 $0 21,400 $1,637,438 13,100 $192,767
2013-08 0 $0 24,401 $1,892,038 16,101 $308,382
2013-07 0 $0 334,098 $27,451,155 320,457 $9,276,790
2013-06 0 $0 13,900 $1,072,174 5,600 $50,792
2013-05 0 $0 124,219 $9,885,389 45,799 $1,335,532
2013-04 0 $0 852,359 $70,595,550 841,317 $30,303,497
2013-02 0 $0 33,345 $1,528,201 0 $0
2013-01 0 $0 2,951 $127,158 2,951 $46,035
2012-12 0 $0 16,000 $668,120 16,000 $249,600
2012-11 1,000 $45,500 37,567 $1,570,889 16,000 $249,600
2012-10 0 $0 85,330 $4,940,702 84,492 $1,434,706
2012-09 0 $0 83,890 $4,767,540 73,890 $1,968,931
2012-08 0 $0 27,453 $1,455,230 27,453 $448,728
2012-07 0 $0 22,500 $1,189,442 22,500 $355,680
2012-06 0 $0 22,500 $1,299,285 22,500 $355,680
2012-05 0 $0 650,671 $38,009,762 630,969 $20,767,644
2012-04 0 $0 16,065 $609,768 16,000 $253,920
2012-03 0 $0 30,562 $1,252,847 23,062 $424,323
2012-02 0 $0 28,741 $1,075,308 0 $0
2012-01 0 $0 26,316 $973,692 0 $0
2011-12 0 $0 9,946 $289,071 9,000 $221,939
2011-11 0 $0 16,653 $520,217 16,000 $394,560
2011-10 0 $0 16,000 $667,972 16,000 $394,560
2011-09 0 $0 73,781 $3,735,191 73,453 $1,383,290
2011-08 0 $0 31,827 $1,451,832 30,453 $614,220
2011-07 0 $0 42,953 $2,172,782 41,453 $860,567
2011-06 0 $0 66,668 $3,430,954 59,168 $1,206,748
2011-05 0 $0 53,524 $2,992,077 28,906 $814,850
2011-04 0 $0 55,953 $2,711,987 55,953 $792,109
2011-03 0 $0 45,672 $2,202,585 41,812 $1,115,279
2011-02 0 $0 107,152 $4,363,996 47,180 $893,116
2011-01 0 $0 32,507 $1,299,250 11,914 $225,532
2010-11 0 $0 2,247 $77,384 1,600 $16,656
2010-10 0 $0 12,884 $481,655 1,600 $16,656
2010-09 0 $0 1,600 $59,552 1,600 $16,656
2010-08 0 $0 1,907 $68,698 1,600 $16,656
2010-07 0 $0 1,600 $54,784 34,100 $477,441
2010-06 0 $0 2,476 $86,311 1,600 $16,656
2010-05 1,300 $49,920 24,171 $873,500 1,600 $16,656
2010-04 1,300 $50,180 19,842 $806,737 1,600 $16,656
2010-03 0 $0 11,600 $499,928 11,600 $401,056
2010-02 6,500 $250,510 7,444 $292,758 1,600 $16,656
2010-01 0 $0 4,209 $167,964 1,600 $16,656
2009-12 0 $0 1,600 $63,391 1,600 $16,656
2009-11 0 $0 27,168 $1,071,077 25,574 $335,275
2009-10 0 $0 27,100 $910,482 25,600 $335,616
2009-09 0 $0 32,000 $1,189,024 32,000 $419,520
2009-08 0 $0 47,513 $1,706,972 46,444 $709,870
2009-07 0 $0 58,291 $2,027,785 54,298 $750,001
2009-06 0 $0 150,801 $5,248,804 148,801 $2,023,141
2009-05 0 $0 149,005 $4,333,132 12,400 $123,754
2009-04 0 $0 15,400 $428,101 12,400 $123,756
2009-03 0 $0 3,650 $104,823 2,400 $23,256
2009-02 0 $0 47,830 $1,663,911 43,612 $535,356
2009-01 0 $0 29,900 $978,612 29,900 $328,530
2008-12 0 $0 18,875 $455,469 14,400 $185,328
2008-11 0 $0 70,890 $1,863,351 54,400 $730,528
2008-10 0 $0 54,508 $1,349,926 45,653 $611,306
2008-09 0 $0 40,804 $1,072,251 40,804 $413,103
2008-08 0 $0 62,824 $1,784,216 62,824 $640,176
2008-07 0 $0 99,161 $3,427,295 96,236 $1,457,777
2008-06 0 $0 3,549 $110,196 8,281 $130,301
2008-05 0 $0 34,451 $938,072 20,000 $283,996
2008-02 83,710 $1,525,569 0 $0 12,735 $200,385
2008-01 0 $0 0 $0 40,000 $463,200
2007-12 0 $0 53,175 $1,350,554 52,686 $720,217
2007-11 4,990 $125,016 140,899 $3,531,318 140,000 $1,913,800
2007-10 0 $0 625 $21,742 625 $8,190
2007-09 0 $0 91,550 $3,661,655 91,550 $2,390,426
2007-08 0 $0 31,220 $1,093,245 31,220 $397,464
2007-07 0 $0 1,125 $34,247 1,125 $13,828
2007-06 50,000 $1,322,500 3,000 $88,530 24,105 $294,980
2007-05 0 $0 115,878 $3,547,710 39,864 $572,267
2007-04 0 $0 25,925 $813,261 25,625 $363,905
2007-03 0 $0 15,273 $434,519 14,950 $143,113
2007-02 0 $0 41,300 $1,358,011 41,000 $590,348
2007-01 0 $0 11,425 $420,406 11,125 $143,845
2006-12 0 $0 88,054 $3,525,963 83,144 $1,162,528
2006-11 0 $0 86,274 $3,808,439 52,686 $840,477
2006-10 0 $0 46,370 $1,686,545 46,070 $742,612
2006-09 0 $0 23,500 $808,095 23,500 $370,025
2006-08 0 $0 107,500 $3,488,828 94,500 $1,170,245
2006-07 0 $0 63,460 $2,251,011 63,460 $813,041
2006-06 0 $0 41,880 $1,408,346 41,880 $475,252
2006-05 455 $14,550 49,416 $1,698,660 46,500 $542,886
2006-04 0 $0 37,820 $1,373,664 37,820 $412,747
2006-03 650 $23,400 50,441 $2,088,486 45,308 $530,571
2006-02 0 $0 49,118 $1,778,206 42,806 $537,689
2006-01 0 $0 30,645 $1,029,048 29,432 $462,587
2005-12 0 $0 30,938 $856,200 0 $0
2005-11 0 $0 600 $15,234 0 $0
2004-07 0 $0 800 $72,688 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Vertex Pharmaceuticals Inc / Ma insiders (VRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-09 Sachdev Amit (EVP, Chief Patient Officer) Sale 5,000 225.00 1,125,000
2019-12-09 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 5,000 109.14 545,700
2019-11-25 Kewalramani Reshma (EVP and CMO) Sale 4,692 219.37 1,029,284
2019-11-25 Kewalramani Reshma (EVP and CMO) Option Ex 4,692 187.53 879,890
2019-11-25 Altshuler David (EVP, Global Research and CSO) Sale 3,910 219.37 857,736
2019-11-25 Altshuler David (EVP, Global Research and CSO) Option Ex 3,910 187.53 733,242
2019-11-25 Sachdev Amit (EVP, Chief Patient Officer) Sale 5,000 220.00 1,100,000
2019-11-25 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 5,000 109.14 545,700
2019-11-19 Sachdev Amit (EVP, Chief Patient Officer) Sale 5,000 215.00 1,075,000
2019-11-19 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 5,000 109.14 545,700
2019-11-19 Leiden Jeffrey M (CEO & President) Sale 96,534 211.53 20,419,837
2019-11-19 Leiden Jeffrey M (CEO & President) Option Ex 96,534 120.52 11,633,795
2019-11-18 Leiden Jeffrey M (CEO & President) Sale 4,434 210.00 931,140
2019-11-18 Leiden Jeffrey M (CEO & President) Option Ex 4,434 120.52 534,363
2019-11-15 Tatsis Ourania (SVP, CRO) Sale 5 205.95 1,029
2019-11-15 Kewalramani Reshma (EVP and CMO) Sale 61 205.95 12,562
2019-11-15 Parini Michael (EVP, CL&AO) Sale 84 205.95 17,299
2019-11-15 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 19 205.95 3,913
2019-11-15 Altshuler David (EVP, Global Research and CSO) Sale 60 205.95 12,357
2019-11-15 Sachdev Amit (EVP, Chief Patient Officer) Sale 57 205.95 11,739
2019-11-15 Leiden Jeffrey M (CEO & President) Sale 5,000 210.00 1,050,000
2019-11-15 Leiden Jeffrey M (CEO & President) Option Ex 5,000 120.52 602,575
2019-11-13 Tatsis Ourania (SVP, CRO) Sale 2,853 205.59 586,548
2019-11-13 Tatsis Ourania (SVP, CRO) Option Ex 2,853 155.57 443,841
2019-11-13 Parini Michael (EVP, CL&AO) Sale 4,892 205.50 1,005,306
2019-11-13 Parini Michael (EVP, CL&AO) Option Ex 4,892 155.57 761,048
2019-11-13 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 8,560 205.57 1,759,679
2019-11-13 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 8,560 155.57 1,331,679
2019-11-08 Kewalramani Reshma (EVP and CMO) Sale 509 199.00 101,291
2019-11-08 Kewalramani Reshma (EVP and CMO) Option Ex 509 155.57 79,185
2019-11-06 Altshuler David (EVP, Global Research and CSO) Sale 1,223 197.12 241,077
2019-11-06 Altshuler David (EVP, Global Research and CSO) Option Ex 1,223 155.57 190,262
2019-11-04 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 3,708 201.62 747,606
2019-11-04 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 3,708 88.78 329,214
2019-11-04 Altshuler David (EVP, Global Research and CSO) Sale 4,126 200.75 828,273
2019-11-04 Altshuler David (EVP, Global Research and CSO) Option Ex 4,126 88.78 366,326
2019-11-04 Sachdev Amit (EVP, Chief Patient Officer) Sale 4,097 200.33 820,752
2019-11-04 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 4,097 88.78 363,752
2019-11-01 Bhatia Sangeeta N. (Director) Sale 1,291 200.00 258,200
2019-11-01 Bhatia Sangeeta N. (Director) Option Ex 1,291 152.74 197,187
2019-10-30 Kewalramani Reshma (EVP and CMO) Sale 3,057 199.00 608,343
2019-10-30 Kewalramani Reshma (EVP and CMO) Option Ex 3,057 155.57 475,577
2019-10-25 Sachdev Amit (EVP, Chief Patient Officer) Sale 4,311 195.01 840,688
2019-10-25 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 4,311 91.05 392,516
2019-10-22 Kewalramani Reshma (EVP and CMO) Sale 638 189.00 120,582
2019-10-22 Altshuler David (EVP, Global Research and CSO) Sale 3,669 194.37 713,143
2019-10-22 Altshuler David (EVP, Global Research and CSO) Option Ex 3,669 155.57 570,786
2019-10-22 Sachdev Amit (EVP, Chief Patient Officer) Sale 3,883 190.27 738,818
2019-10-22 Sachdev Amit (EVP, Chief Patient Officer) Option Ex 3,883 86.52 335,957
2019-10-22 Leiden Jeffrey M (CEO & President) Sale 107,831 190.00 20,487,890
2019-10-22 Leiden Jeffrey M (CEO & President) Option Ex 107,831 120.52 12,995,252
2019-10-22 Mcglynn Margaret G (Director) Sale 20,000 190.00 3,800,000
2019-10-22 Mcglynn Margaret G (Director) Option Ex 20,000 72.14 1,442,800
2019-10-17 Parini Michael (EVP, CL&AO) Sale 4,250 177.80 755,650
2019-10-17 Parini Michael (EVP, CL&AO) Option Ex 4,250 122.45 520,412
2019-10-14 Parini Michael (EVP, CL&AO) Sale 2,125 174.33 370,457
2019-10-14 Parini Michael (EVP, CL&AO) Option Ex 2,125 90.29 191,866
2019-10-02 Tatsis Ourania (SVP, CRO) Sale 444 167.69 74,454
2019-10-02 Bhatia Sangeeta N. (Director) Sale 8,379 166.93 1,398,681
2019-10-02 Bhatia Sangeeta N. (Director) Option Ex 7,088 126.19 894,470
2019-10-01 Tatsis Ourania (SVP, CRO) Sale 188 169.11 31,792
2019-08-19 Altshuler David (EVP, Global Research and CSO) Sale 12,501 186.39 2,330,011
2019-08-19 Altshuler David (EVP, Global Research and CSO) Option Ex 12,501 103.15 1,289,515
2019-08-13 Mcglynn Margaret G (Director) Sale 10,000 185.00 1,850,000
2019-08-13 Mcglynn Margaret G (Director) Option Ex 10,000 81.54 815,400
2019-08-08 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,125 181.89 386,516
2019-08-08 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 131.89 280,266
2019-08-05 Parini Michael (EVP, CL&AO) Sale 2,330 175.12 408,041
2019-08-05 Parini Michael (EVP, CL&AO) Option Ex 2,330 86.52 201,591
2019-08-05 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 1,553 176.44 274,011
2019-08-05 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 1,553 86.52 134,365
2019-08-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,155 177.78 383,115
2019-08-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,155 91.05 196,212
2019-07-12 Parini Michael (EVP, CL&AO) Sale 2,125 175.41 372,746
2019-07-12 Parini Michael (EVP, CL&AO) Option Ex 2,125 90.29 191,866
2019-07-05 Parini Michael (EVP, CL&AO) Sale 4,250 180.11 765,467
2019-07-05 Parini Michael (EVP, CL&AO) Option Ex 4,250 122.45 520,412
2019-06-19 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,125 181.89 386,516
2019-06-19 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 131.89 280,266
2019-06-18 Leiden Jeffrey M (CEO & President) Sale 56,030 175.72 9,845,591
2019-06-18 Leiden Jeffrey M (CEO & President) Option Ex 56,030 77.31 4,331,679
2019-06-03 Bhatia Sangeeta N. (Director) Sale 720 167.15 120,348
2019-05-30 Parini Michael (EVP, CL&AO) Sale 707 173.00 122,311
2019-05-24 Leiden Jeffrey M (CEO & President) Sale 113,432 175.10 19,861,943
2019-05-24 Leiden Jeffrey M (CEO & President) Option Ex 113,432 77.31 8,769,427
2019-05-15 Kewalramani Reshma (EVP and CMO) Sale 241 165.41 39,863
2019-05-15 Parini Michael (EVP, CL&AO) Sale 83 165.41 13,729
2019-05-15 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 133 165.41 21,999
2019-05-15 Altshuler David (EVP, Global Research and CSO) Sale 91 165.41 15,052
2019-05-15 Silva Paul M (SVP & Controller) Sale 161 165.41 26,631
2019-05-15 Sachdev Amit (EVP, CRO) Sale 61 165.41 10,090
2019-05-06 Leiden Jeffrey M (CEO & President) Sale 33,058 175.01 5,785,645
2019-05-06 Leiden Jeffrey M (CEO & President) Option Ex 33,058 77.31 2,555,713
2019-05-03 Parini Michael (EVP, CL&AO) Sale 1,622 171.92 278,854
2019-05-03 Parini Michael (EVP, CL&AO) Option Ex 2,329 86.52 201,505
2019-05-03 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 1,553 171.98 267,084
2019-05-03 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 1,553 86.52 134,365
2019-05-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,155 170.07 366,507
2019-05-02 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,155 91.05 196,212
2019-04-16 Parini Michael (EVP, CL&AO) Sale 6,375 182.22 1,161,684
2019-04-16 Parini Michael (EVP, CL&AO) Option Ex 6,375 106.37 678,108
2019-04-15 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 5,624 182.28 1,025,159
2019-02-19 Kewalramani Reshma (EVP and CMO) Sale 1,488 187.50 279,004
2019-02-19 Parini Michael (EVP, CL&AO) Sale 5,624 187.58 1,054,966
2019-02-19 Altshuler David (EVP, Global Research and CSO) Sale 5,624 187.60 1,055,062
2019-02-19 Silva Paul M (SVP & Interim CFO) Sale 2,812 187.51 527,269
2019-02-19 Leiden Jeffrey M (CEO & President) Sale 20,997 187.61 3,939,310
2019-02-11 Silva Paul M (SVP & Interim CFO) Sale 4,215 180.27 759,850
2019-02-06 Silva Paul M (SVP & Interim CFO) Sale 1,289 193.00 248,777
2019-02-06 Silva Paul M (SVP & Interim CFO) Option Ex 1,289 91.05 117,363
2019-02-04 Parini Michael (EVP, CL&AO) Sale 2,330 189.19 440,812
2019-02-04 Parini Michael (EVP, CL&AO) Option Ex 2,330 86.52 201,591
2019-02-04 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 18,309 186.46 3,413,804
2019-02-04 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 7,959 95.66 761,357
2019-02-04 Altshuler David (EVP, Global Research and CSO) Sale 4,126 189.19 780,597
2019-02-04 Altshuler David (EVP, Global Research and CSO) Option Ex 4,126 88.78 366,326
2019-02-04 Silva Paul M (SVP & Interim CFO) Sale 4,247 187.13 794,741
2019-02-04 Silva Paul M (SVP & Interim CFO) Option Ex 809 86.52 69,994
2019-02-04 Sachdev Amit (EVP, CRO) Sale 12,722 186.92 2,377,996
2019-02-04 Sachdev Amit (EVP, CRO) Option Ex 4,097 88.78 363,752
2019-02-04 Leiden Jeffrey M (CEO & President) Sale 32,250 186.43 6,012,206
2019-02-01 Parini Michael (EVP, CL&AO) Sale 3,450 190.92 658,674
2019-01-22 Parini Michael (EVP, CL&AO) Sale 3,668 195.00 715,260
2019-01-22 Parini Michael (EVP, CL&AO) Option Ex 3,668 155.57 570,630
2019-01-22 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,125 193.48 411,145
2019-01-22 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 131.89 280,266
2019-01-22 Altshuler David (EVP, Global Research and CSO) Sale 2,125 193.48 411,145
2019-01-22 Altshuler David (EVP, Global Research and CSO) Option Ex 2,125 131.89 280,266
2019-01-18 Altshuler David (EVP, Global Research and CSO) Sale 1,223 194.62 238,020
2019-01-18 Altshuler David (EVP, Global Research and CSO) Option Ex 1,223 155.70 190,421
2019-01-17 Silva Paul M (SVP & Corp Controller) Sale 3,007 190.54 572,962
2019-01-17 Silva Paul M (SVP & Corp Controller) Option Ex 3,007 90.54 272,262
2019-01-14 Parini Michael (EVP, CL&AO) Sale 2,125 186.71 396,758
2019-01-14 Parini Michael (EVP, CL&AO) Option Ex 2,125 90.29 191,866
2019-01-04 Parini Michael (EVP, CL&AO) Sale 4,250 165.90 705,075
2019-01-04 Parini Michael (EVP, CL&AO) Option Ex 4,250 122.45 520,412
2018-12-06 Sachs Bruce I (Director) Option Ex 10,000 34.24 342,400
2018-12-03 Silva Paul M (SVP & Corp Controller) Sale 809 186.52 150,894
2018-12-03 Silva Paul M (SVP & Corp Controller) Option Ex 809 86.52 69,994
2018-11-15 Parini Michael (EVP, CL&AO) Sale 90 163.75 14,737
2018-11-15 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 29 163.75 4,748
2018-11-15 Altshuler David (EVP, Global Research and CSO) Sale 100 163.75 16,375
2018-11-15 Silva Paul M (SVP & Corp Controller) Sale 12 163.75 1,965
2018-11-07 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 2,125 179.00 380,375
2018-11-07 Arbuckle Stuart A (EVP\Chief Commercial Officer) Option Ex 2,125 131.89 280,266
2018-11-07 Altshuler David (EVP, Global Research and CSO) Sale 2,125 181.89 386,516
2018-11-07 Altshuler David (EVP, Global Research and CSO) Option Ex 2,125 131.89 280,266
2018-11-05 Parini Michael (EVP, CL&AO) Sale 2,330 172.08 400,946
2018-11-05 Parini Michael (EVP, CL&AO) Option Ex 2,330 86.52 201,591
2018-11-05 Arbuckle Stuart A (EVP\Chief Commercial Officer) Sale 5,803 172.08 998,580

Insider trading activities including stock purchases, stock sales, and option exercises of VRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX, CIK number 875320) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month